BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12062184)

  • 1. Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation.
    Mohamad SB; Nagasawa H; Uto Y; Hori H
    Comp Biochem Physiol A Mol Integr Physiol; 2002 May; 132(1):1-8. PubMed ID: 12062184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effect of vitamin D-binding protein-derived macrophage activating factor on Ehrlich ascites tumor-bearing mice.
    Koga Y; Naraparaju VR; Yamamoto N
    Proc Soc Exp Biol Med; 1999 Jan; 220(1):20-6. PubMed ID: 9893164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
    Yamamoto N; Naraparaju VR
    Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF).
    Yamamoto N; Suyama H; Yamamoto N; Ushijima N
    Int J Cancer; 2008 Jan; 122(2):461-7. PubMed ID: 17935130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF.
    Yamamoto N; Suyama H; Nakazato H; Yamamoto N; Koga Y
    Cancer Immunol Immunother; 2008 Jul; 57(7):1007-16. PubMed ID: 18058096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of salivary gland adenocarcinoma cell-derived alpha-N-acetylgalactosaminidase on the bioactivity of macrophage activating factor.
    Matsuura T; Uematsu T; Yamaoka M; Furusawa K
    Int J Oncol; 2004 Mar; 24(3):521-8. PubMed ID: 14767536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF).
    Yamamoto N; Ushijima N; Koga Y
    J Med Virol; 2009 Jan; 81(1):16-26. PubMed ID: 19031451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of Gc protein-derived macrophage activating factor (GcMAF) and its structural characterization and biological activities.
    Mohamad SB; Nagasawa H; Uto Y; Hori H
    Anticancer Res; 2002; 22(6C):4297-300. PubMed ID: 12553073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degalactosylated/desialylated human serum containing GcMAF induces macrophage phagocytic activity and in vivo antitumor activity.
    Kuchiike D; Uto Y; Mukai H; Ishiyama N; Abe C; Tanaka D; Kawai T; Kubo K; Mette M; Inui T; Endo Y; Hori H
    Anticancer Res; 2013 Jul; 33(7):2881-5. PubMed ID: 23780974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GC protein-derived macrophage-activating factor decreases α-
    Thyer L; Ward E; Smith R; Branca JJ; Morucci G; Gulisano M; Noakes D; Eslinger R; Pacini S
    Oncoimmunology; 2013 Aug; 2(8):e25769. PubMed ID: 24179708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Fucoidan from the Brown Alga
    Bakunina I; Chadova O; Malyarenko O; Ermakova S
    Mar Drugs; 2018 May; 16(5):. PubMed ID: 29748462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF.
    Yamamoto N; Suyama H; Yamamoto N
    Transl Oncol; 2008 Jul; 1(2):65-72. PubMed ID: 18633461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural modification of serum vitamin D3-binding protein and immunosuppression in AIDS patients.
    Yamamoto N; Naraparaju VR; Srinivasula SM
    AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1373-8. PubMed ID: 8573395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is α-N-acetylgalactosaminidase the key to curing cancer? A mini-review and hypothesis.
    Saburi E; Tavakol-Afshari J; Biglari S; Mortazavi Y
    J BUON; 2017; 22(6):1372-1377. PubMed ID: 29332325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gc protein-derived macrophage activating factor (GcMAF): isoelectric focusing pattern and tumoricidal activity.
    Mohamad SB; Nagasawa H; Sasaki H; Uto Y; Nakagawa Y; Kawashima K; Hori H
    Anticancer Res; 2003; 23(6a):4451-7. PubMed ID: 14666733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy with GcMAF revisited - A critical overview of the research of Nobuto Yamamoto.
    Albracht SP
    Cancer Treat Res Commun; 2022; 31():100537. PubMed ID: 35217488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deglycosylation of serum vitamin D3-binding protein by alpha-N-acetylgalactosaminidase detected in the plasma of patients with systemic lupus erythematosus.
    Yamamoto N; Naraparaju VR; Moore M; Brent LH
    Clin Immunol Immunopathol; 1997 Mar; 82(3):290-8. PubMed ID: 9073553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structurally well-defined macrophage activating factor derived from vitamin D3-binding protein has a potent adjuvant activity for immunization.
    Yamamoto N; Naraparaju VR
    Immunol Cell Biol; 1998 Jun; 76(3):237-44. PubMed ID: 9682967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum alpha-N-acetylgalactosaminidase is associated with diagnosis/prognosis of patients with squamous cell carcinoma of the uterine cervix.
    Reddi AL; Sankaranarayanan K; Arulraj HS; Devaraj N; Devaraj H
    Cancer Lett; 2000 Sep; 158(1):61-4. PubMed ID: 10940510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel assay system for macrophage-activating factor activity using a human U937 cell line.
    Ishikawa M; Inoue T; Inui T; Kuchiike D; Kubo K; Uto Y; Nishikata T
    Anticancer Res; 2014 Aug; 34(8):4577-81. PubMed ID: 25075102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.